ProfileGDS4516 / 218113_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 88% 89% 71% 81% 82% 79% 84% 87% 79% 73% 84% 83% 83% 96% 82% 85% 77% 83% 81% 75% 88% 87% 76% 80% 82% 81% 86% 80% 56% 82% 86% 75% 83% 67% 82% 74% 90% 88% 86% 80% 89% 82% 72% 81% 87% 88% 81% 78% 86% 78% 74% 83% 86% 85% 78% 80% 85% 65% 76% 81% 79% 85% 77% 82% 81% 86% 82% 84% 76% 85% 88% 81% 86% 78% 73% 78% 90% 83% 87% 83% 73% 83% 82% 76% 78% 85% 73% 88% 79% 83% 82% 88% 78% 79% 80% 83% 84% 81% 80% 80% 82% 78% 76% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]8.9859588
GSM537345patient 119, cancer, LCM [OPG study]9.247589
GSM537355patient 138, cancer, LCM [OPG study]6.9812271
GSM537366patient 154, cancer, LCM [OPG study]8.0841881
GSM537370patient 022, cancer, LCM [OPG study]8.3185382
GSM537380patient 037, cancer, LCM [OPG study]7.7789279
GSM537392patient 077, cancer, LCM [OPG study]8.4986484
GSM537415patient 032, cancer, LCM [OPG study]9.0467687
GSM537417patient 042, cancer, LCM [OPG study]7.6976779
GSM537422patient 059, cancer, LCM [OPG study]7.1687373
GSM537423patient 064, cancer, LCM [OPG study]8.457384
GSM537427patient 084, cancer, LCM [OPG study]8.4038283
GSM537430patient 090, cancer, LCM [OPG study]8.2996283
GSM537336patient 107, cancer, LCM [OPG study]10.640696
GSM537337patient 108, cancer, LCM [OPG study]8.2427982
GSM537348patient 124, cancer, LCM [OPG study]8.5096185
GSM537349patient 125, cancer, LCM [OPG study]7.6112777
GSM537356patient 139, cancer, LCM [OPG study]8.33383
GSM537361patient 147, cancer, LCM [OPG study]7.9197481
GSM537374patient 026, cancer, LCM [OPG study]7.2852975
GSM537377patient 033, cancer, LCM [OPG study]8.8675188
GSM537378patient 034, cancer, LCM [OPG study]8.9059187
GSM537379patient 036, cancer, LCM [OPG study]7.4173676
GSM537383patient 046, cancer, LCM [OPG study]7.9714380
GSM537388patient 063, cancer, LCM [OPG study]8.1971882
GSM537395patient 082, cancer, LCM [OPG study]8.1290281
GSM537400patient 099, cancer, LCM [OPG study]8.7894386
GSM537404patient 129, cancer, LCM [OPG study]7.6837980
GSM537409patient 141, cancer, LCM [OPG study]5.7485956
GSM537418patient 044, cancer, LCM [OPG study]8.3428282
GSM537425patient 070, cancer, LCM [OPG study]8.7440386
GSM537333patient 102, cancer, LCM [OPG study]7.3172175
GSM537342patient 116, cancer, LCM [OPG study]8.3239683
GSM537347patient 123, cancer, LCM [OPG study]6.6088167
GSM537350patient 127, cancer, LCM [OPG study]8.1518482
GSM537362patient 148, cancer, LCM [OPG study]7.2158674
GSM537363patient 150, cancer, LCM [OPG study]9.2711290
GSM537368patient 156, cancer, LCM [OPG study]8.8931988
GSM537376patient 031, cancer, LCM [OPG study]8.6748986
GSM537381patient 038, cancer, LCM [OPG study]7.926780
GSM537386patient 057, cancer, LCM [OPG study]9.1479489
GSM537398patient 094, cancer, LCM [OPG study]8.1794282
GSM537402patient 109, cancer, LCM [OPG study]7.048572
GSM537405patient 130, cancer, LCM [OPG study]7.96381
GSM537371patient 023, cancer, LCM [OPG study]8.9906187
GSM537421patient 055, cancer, LCM [OPG study]8.9711788
GSM537424patient 065, cancer, LCM [OPG study]8.0051381
GSM537432patient 097, cancer, LCM [OPG study]7.7015978
GSM537331patient 100, cancer, LCM [OPG study]8.5894586
GSM537332patient 101, cancer, LCM [OPG study]7.7843678
GSM537334patient 103, cancer, LCM [OPG study]7.1877674
GSM537338patient 110, cancer, LCM [OPG study]8.2247983
GSM537353patient 135, cancer, LCM [OPG study]8.687686
GSM537357patient 142, cancer, LCM [OPG study]8.6515185
GSM537358patient 143, cancer, LCM [OPG study]7.6469478
GSM537375patient 030, cancer, LCM [OPG study]7.823980
GSM537389patient 068, cancer, LCM [OPG study]8.7500885
GSM537390patient 072, cancer, LCM [OPG study]6.4234765
GSM537393patient 078, cancer, LCM [OPG study]7.5402176
GSM537399patient 095, cancer, LCM [OPG study]7.9027281
GSM537407patient 133, cancer, LCM [OPG study]7.6350279
GSM537408patient 140, cancer, LCM [OPG study]8.5914785
GSM537428patient 086, cancer, LCM [OPG study]7.5341677
GSM537354patient 136, cancer, LCM [OPG study]8.2041682
GSM537410patient 146, cancer, LCM [OPG study]8.0693981
GSM537413patient 027, cancer, LCM [OPG study]8.9496786
GSM537396patient 083, cancer, LCM [OPG study]8.3002182
GSM537397patient 088, cancer, LCM [OPG study]8.5321884
GSM537330patient 006, cancer, LCM [OPG study]7.4441476
GSM537369patient 015, cancer, LCM [OPG study]8.6377485
GSM537373patient 025, cancer, LCM [OPG study]9.0962488
GSM537401patient 106, cancer, LCM [OPG study]8.0140881
GSM537343patient 117, cancer, LCM [OPG study]8.7267986
GSM537367patient 155, cancer, LCM [OPG study]7.6312878
GSM537382patient 041, cancer, LCM [OPG study]7.222673
GSM537385patient 053, cancer, LCM [OPG study]7.7028978
GSM537391patient 073, cancer, LCM [OPG study]9.3238790
GSM537419patient 045, cancer, LCM [OPG study]8.1295583
GSM537420patient 052, cancer, LCM [OPG study]8.6367787
GSM537429patient 089, cancer, LCM [OPG study]8.3822283
GSM537431patient 096, cancer, LCM [OPG study]7.0354673
GSM537387patient 061, cancer, LCM [OPG study]8.3191483
GSM537414patient 028, cancer, LCM [OPG study]8.2445682
GSM537433patient 098, cancer, LCM [OPG study]7.4926876
GSM537335patient 104, cancer, LCM [OPG study]7.7348178
GSM537339patient 111, cancer, LCM [OPG study]8.7939185
GSM537340patient 113, cancer, LCM [OPG study]7.1478173
GSM537344patient 118, cancer, LCM [OPG study]9.0933288
GSM537346patient 011, cancer, LCM [OPG study]7.9481479
GSM537351patient 128, cancer, LCM [OPG study]8.2766483
GSM537352patient 134, cancer, LCM [OPG study]8.1884782
GSM537359patient 144, cancer, LCM [OPG study]8.9028588
GSM537360patient 145, cancer, LCM [OPG study]7.6875178
GSM537364patient 152, cancer, LCM [OPG study]7.7930179
GSM537365patient 153, cancer, LCM [OPG study]7.9561880
GSM537372patient 024, cancer, LCM [OPG study]8.1865583
GSM537384patient 048, cancer, LCM [OPG study]8.3582684
GSM537394patient 081, cancer, LCM [OPG study]8.0390881
GSM537403patient 121, cancer, LCM [OPG study]7.8320180
GSM537406patient 131, cancer, LCM [OPG study]7.8556580
GSM537411patient 149, cancer, LCM [OPG study]8.0783382
GSM537412patient 019, cancer, LCM [OPG study]7.6009378
GSM537416patient 035, cancer, LCM [OPG study]7.5132776
GSM537426patient 079, cancer, LCM [OPG study]7.4625875